comparemela.com

Gao Yi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Schools cancel classes Wednesday amid cold snap

Schools cancel classes Wednesday amid cold snap
focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.

Schools cancel classes Wednesday amid cold snap

Schools cancel classes Wednesday amid cold snap
focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.

Three northern schools to cancel classes, work due to cold snap

Three northern schools to cancel classes, work due to cold snap
focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.

PLA Southern Theater Command conducts live-fire drills along China-Myanmar border

PLA Southern Theater Command conducts live-fire drills along China-Myanmar border
chinamil.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinamil.com.cn Daily Mail and Mail on Sunday newspapers.

Groundbreaking artificial liver therapy approved for clinical trials in China

A stem cell-based bio-artificial liver therapy developed by scientists in China has received approval for clinical trials. Groundbreaking therapy system: The Chinese research team, led by Dr. Gao Yi from the Translational Medicine Centre at Zhujiang Hospital of Southern Medical University, developed the bio-artificial liver system that uses a bioreactor to perform the essential functions of the liver, such as detoxification and protein synthesis, outside the body. Deadly disease: Liver disease is responsible for 4% of all deaths, accounting for 2 million fatalities around the world each year.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.